Lillys retatrutide (triple agonist targeting GLP1, GIP and glucagon) promises to be the most potent of all
The search terms (combined with Boolean operators) used were obesity AND (phenotype OR precision medicine OR endotype) AND (pharmacotherapy OR GLP- 1 receptor agonist OR tirzepatide OR semaglutide OR liraglutide, OR phentermine topiramate OR naltrexone bupropion OR orlistat OR anti- obesity medication OR bariatric surgery) AND (RCT OR trial OR real- world evidence) AND (children OR older adult OR T2D OR HFpEF OR CKD OR MASLD OR OSA OR sarcopenia OR binge eating OR emotional eating OR PCOS)
The analysis of fissure numbers per microscopy field across different experimental groups reveals significant variations in brain tissue morphology (Figure 8B, F (5, 30) = 48.51, p 0.05)
Medicare spending on GLP-1s has surged, raising concerns about long-term affordability and access 2
Glutathione helps stave off the impact of oxidative stress, which may, in turn, reduce disease
PCOS affects 8% to 13% of reproductive-age women (Bozdag et al., Human Reproduction , 2016)
